Insight Molecular Diagnostics (IMDX) Total Debt Growth (1y) (2017 - 2026)
Insight Molecular Diagnostics (IMDX) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 257.85% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 26.24% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 12.18% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 33.69% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 108.22% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 10.49% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -72.10% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -0.07% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 7.45% |
| 10 | Insight Molecular Diagnostics | 4.34 Mn | -24.59 Mn | 15,000.00 | -63.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.28% |
| Dec 31, 2025 | 87.72% |
| Sep 30, 2025 | 71.99% |
| Dec 31, 2024 | -90.15% |
| Sep 30, 2024 | 463.30% |
| Dec 31, 2023 | 2,022.94% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -82.10% |
| Mar 31, 2023 | -82.53% |
| Dec 31, 2022 | -92.15% |
| Sep 30, 2022 | -93.50% |
| Jun 30, 2022 | -95.04% |
| Mar 31, 2022 | -82.38% |
| Dec 31, 2021 | -64.39% |
| Sep 30, 2021 | -59.33% |
| Jun 30, 2021 | 199.10% |
| Mar 31, 2021 | 15.53% |
| Dec 31, 2020 | 103.98% |
| Sep 30, 2020 | 615.08% |
| Jun 30, 2020 | 81,980.00% |